Li, Xiaopan
Zhou, Yi
Luo, Zheng
Gu, Yi’an
Chen, Yichen
Yang, Chen
Wang, Jing
Xiao, Shaotan
Sun, Qiao
Qian, Mengcen
Zhao, Genming http://orcid.org/0000-0002-9625-478X
Funding for this research was provided by:
National Key R & D Program of China (2017YFC09070000)
Foundation of Shanghai Municipal Commission of Health and Family Planning (201540407)
the Young Medical Talents Training Program of the Pudong Health Bureau of Shanghai (PWRq2017-33)
Fund of Key Discipline Construction in Pudong New Area Health System (PWZxk2017-28)
Shanghai Municipal Health Bureau (20164Y0083)
Article History
Received: 26 October 2018
Accepted: 15 July 2019
First Online: 29 July 2019
Ethics approval and consent to participate
: Our study did not involve any health-related human participants’ interventions. The data collecting protocols of the cancer registry and the screening program conformed to the ethical guidelines of the 1975 Declaration of Helsinki and were approved by the institutional review board of Centers for Disease Control and Prevention (CDC) of PNA. All patients in this study provided informed consent by themselves or their families. The patients were followed up by primary care physicians at a frequency of no less than 6 months since their diagnosis until death.
: The study was approved for publication by all authors.
: The authors declare that they have no competing interests.